Accounting for 10–20% of newly diagnosed breast cancer cases, triple-negative breast cancer (TNBC) is characterized by the lack of hormone receptor expression and lack of HER2/NEU gene overexpression (Dent et al., 2007). The gene discussed is ERBB2; the disease is breast carcinoma.